Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Cash and Short Term Investments (Quarterly): 1.263B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.263B |
September 30, 2023 | 1.342B |
June 30, 2023 | 1.437B |
March 31, 2023 | 1.474B |
December 31, 2022 | 1.124B |
September 30, 2022 | 1.192B |
June 30, 2022 | 407.41M |
March 31, 2022 | 443.19M |
December 31, 2021 | 493.99M |
September 30, 2021 | 498.90M |
June 30, 2021 | 543.63M |
Date | Value |
---|---|
March 31, 2021 | 571.30M |
December 31, 2020 | 322.33M |
September 30, 2020 | 344.90M |
June 30, 2020 | 367.58M |
March 31, 2020 | 383.49M |
December 31, 2019 | 389.40M |
September 30, 2019 | 161.60M |
June 30, 2019 | 75.30M |
March 31, 2019 | 84.28M |
December 31, 2018 | 13.89M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
75.30M
Minimum
Jun 2019
1.474B
Maximum
Mar 2023
675.49M
Average
493.99M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 9.67B |
RayzeBio inc (DELISTED) | 540.17M |
Icosavax Inc (DELISTED) | 229.21M |
Madrigal Pharmaceuticals Inc | 1.059B |
Theseus Pharmaceuticals Inc (DELISTED) | 205.12M |